This collection
is approved conditional on the following terms: 1. The agency will
clearly indicate that estimates yielded from this study are
representative of adult males in selected counties physically able
to give informed consent within the 24 hours of their arrest (the
study is not nationally or regionally representative); and 2.
Should the ADAM study be extended, the agency will meet with OIRA
to discuss proposed sampling design in advance of providing notice
in the Federal Register.
Inventory as of this Action
Requested
Previously Approved
05/31/2014
36 Months From Approved
05/31/2013
1,750
0
5,000
765
0
1,853
0
0
1,653,540
A purposive, non-probability sample of
sentinel sights (not representative of the US as a whole or
individual states or other areas that were not surveyed) that
replicates the ADAM methodology in order to obtain data comparable
to previously established trends in 5 of the prior ADAM sites. ADAM
II implements one quarter of data collection in five sentinel ADAM
sites to revive monitoring drug trends, with a particular focus on
obtaining valid and reliable information on methamphetamine
use.
The number of sites were
reduced to 5 and the number of quarters reduced to 1 due to budget
limitations. To ensure sufficient samples were collected in the
ramining sites to enable annual estimations, the number of weeks
for data collection were increased from 2 to 3. The annual cost
burden was reduced to zero because it consisted of labor costs that
were already accounted for in the Annual Time Burden (Hr)
column.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.